Protara Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 5.14 M | $27.38 M | 21.51% | 12.16% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/13/2026 | 2.83 M | $15.11 M | 32.52% | 6.71% |
| BLACKROCK, INC. | 02/12/2026 | 2.41 M | $12.84 M | 8.05% | 5.70% |
| VANGUARD GROUP INC | 01/29/2026 | 2.39 M | $12.75 M | 25.61% | 5.66% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 2.25 M | $11.99 M | 60.71% | 5.32% |
| BLACKSTONE INC. | 02/17/2026 | 1.91 M | $10.18 M | 0.00% | 4.52% |
| ACORN CAPITAL ADVISORS, LLC | 02/17/2026 | 1.75 M | $9.34 M | 0.00% | 4.14% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 1.72 M | $9.14 M | 100.00% | 4.06% |
| CATALIO CAPITAL MANAGEMENT, LP | 02/17/2026 | 1.45 M | $7.71 M | -3.63% | 3.42% |
| 5AM VENTURE MANAGEMENT, LLC | 02/17/2026 | 1.37 M | $7.30 M | 71.22% | 3.24% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.26 M | $6.71 M | 183.37% | 2.98% |
| UBS GROUP AG | 01/29/2026 | 1.22 M | $6.48 M | 44.18% | 2.88% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 1.14 M | $6.06 M | 3,127.43% | 2.69% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 1.04 M | $5.56 M | 100.00% | 2.47% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 971.61 K | $5.18 M | 80.99% | 2.30% |
| CITADEL ADVISORS LLC | 02/17/2026 | 901.54 K | $4.81 M | 79.43% | 2.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 817.20 K | $4.36 M | 7.71% | 1.93% |
| MAVEN SECURITIES LTD | 02/13/2026 | 754.63 K | $4.02 M | 100.00% | 1.79% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 753.30 K | $4.02 M | 9.45% | 1.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 650.00 K | $3.46 M | 100.00% | 1.54% |
| MARSHALL WACE, LLP | 02/13/2026 | 584.53 K | $3.12 M | 104.68% | 1.38% |
| STATE STREET CORP | 02/13/2026 | 570.88 K | $3.04 M | 63.07% | 1.35% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 495.90 K | $2.64 M | 174.78% | 1.17% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 02/17/2026 | 450.00 K | $2.40 M | 100.00% | 1.06% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/17/2026 | 360.00 K | $1.92 M | 0.00% | 0.85% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 350.00 K | $1.87 M | 100.00% | 0.83% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 308.33 K | $1.64 M | 0.30% | 0.73% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 266.81 K | $1.42 M | -15.11% | 0.63% |
| NORTHERN TRUST CORP | 02/17/2026 | 240.76 K | $1.28 M | 2.73% | 0.57% |
| CIBC WORLD MARKET INC. | 02/10/2026 | 228.90 K | $1.22 M | -16.76% | 0.54% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 227.16 K | $1.21 M | 376.14% | 0.54% |
| OPPENHEIMER & CO INC | 02/02/2026 | 223.77 K | $1.19 M | 8.11% | 0.53% |
| MORGAN STANLEY | 02/13/2026 | 175.33 K | $934.50 K | 61.53% | 0.41% |
| JANE STREET GROUP, LLC | 02/12/2026 | 156.14 K | $832.20 K | 245.08% | 0.37% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 153.99 K | $820.74 K | 100.00% | 0.36% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 145.88 K | $777.52 K | 100.00% | 0.35% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 02/12/2026 | 125.00 K | $666.25 K | 100.00% | 0.30% |
| XTX TOPCO LTD | 02/17/2026 | 115.36 K | $614.89 K | 100.00% | 0.27% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 114.33 K | $609.38 K | 100.00% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 106.85 K | $569.49 K | 31.58% | 0.25% |
| EAM INVESTORS, LLC | 02/12/2026 | 103.61 K | $552.25 K | 100.00% | 0.25% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 102.50 K | $546.32 K | 7.02% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 93.52 K | $498.47 K | -3.58% | 0.22% |
| NUVEEN, LLC | 02/12/2026 | 86.50 K | $461.05 K | -69.49% | 0.20% |
| MAREX GROUP PLC | 02/12/2026 | 85.25 K | $454.38 K | 283.15% | 0.20% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 68.96 K | $368.00 K | 100.00% | 0.16% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 64.16 K | $341.96 K | 4.23% | 0.15% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 63.49 K | $338.41 K | 366.58% | 0.15% |
| SEI INVESTMENTS CO | 02/13/2026 | 63.08 K | $336.21 K | 100.00% | 0.15% |
| BARCLAYS PLC | 02/13/2026 | 55.06 K | $293.45 K | 20.95% | 0.13% |
Protara Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 118 institutional investors and hedge funds held shares of Protara Therapeutics Inc. The most heavily invested institutionals were:
JANUS HENDERSON GROUP PLC: 5.14 M
Velan Capital Investment Management LP: 2.83 M
BlackRock, Inc.: 2.41 M
VANGUARD GROUP INC: 2.39 M
Integral Health Asset Management, LLC: 2.25 M
Blackstone Inc.: 1.91 M
94.19% of Protara Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 41.10 M shares in the last 24 months. This purchase volume represents approximately $277.41 M in transactions.